1. Home
  2. VS vs RLMD Comparison

VS vs RLMD Comparison

Compare VS & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • RLMD
  • Stock Information
  • Founded
  • VS 2013
  • RLMD 2004
  • Country
  • VS Canada
  • RLMD United States
  • Employees
  • VS N/A
  • RLMD N/A
  • Industry
  • VS EDP Services
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • VS Technology
  • RLMD Health Care
  • Exchange
  • VS Nasdaq
  • RLMD Nasdaq
  • Market Cap
  • VS 9.7M
  • RLMD 11.5M
  • IPO Year
  • VS N/A
  • RLMD N/A
  • Fundamental
  • Price
  • VS $2.10
  • RLMD $0.28
  • Analyst Decision
  • VS Hold
  • RLMD Hold
  • Analyst Count
  • VS 1
  • RLMD 4
  • Target Price
  • VS $2.00
  • RLMD $4.25
  • AVG Volume (30 Days)
  • VS 27.7K
  • RLMD 379.0K
  • Earning Date
  • VS 05-14-2025
  • RLMD 03-27-2025
  • Dividend Yield
  • VS N/A
  • RLMD N/A
  • EPS Growth
  • VS N/A
  • RLMD N/A
  • EPS
  • VS N/A
  • RLMD N/A
  • Revenue
  • VS $57,288.00
  • RLMD N/A
  • Revenue This Year
  • VS N/A
  • RLMD N/A
  • Revenue Next Year
  • VS $2,099.57
  • RLMD N/A
  • P/E Ratio
  • VS N/A
  • RLMD N/A
  • Revenue Growth
  • VS N/A
  • RLMD N/A
  • 52 Week Low
  • VS $1.00
  • RLMD $0.24
  • 52 Week High
  • VS $9.59
  • RLMD $5.09
  • Technical
  • Relative Strength Index (RSI)
  • VS 47.58
  • RLMD 37.78
  • Support Level
  • VS $2.04
  • RLMD $0.26
  • Resistance Level
  • VS $2.52
  • RLMD $0.32
  • Average True Range (ATR)
  • VS 0.14
  • RLMD 0.02
  • MACD
  • VS -0.00
  • RLMD 0.00
  • Stochastic Oscillator
  • VS 24.56
  • RLMD 15.94

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: